-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS INC : RBC CUTS TARGET PRICE TO $350 FROM $445

Reuters·07/31/2026 06:49:14

Please log in to view news